“The utility of using isolated marijuana use as a criterion for urine drug screening appears limited in benefit but rife with inequitable potential to harm,” authors concluded.
Authors predicted, “If the remaining … states without medical cannabis legalization were to legalize cannabis, spending on conventional pharmaceutical drugs would decrease by almost 11 percent.”
“Cannabidiol should be considered as a treatment option in managing symptoms related to autism,” investigators concluded.
Subjects exhibited modest improvements following the administration of THC-dominant cannabis, but they failed to demonstrate similar improvements following the use of lower potency varieties.
Judges opined that the state’s employee protection law only provides protections for activities defined as legal under both state and federal law.
Investigators concluded, “Our results … may help to reduce [the] stigma experienced by people who use cannabis.”
Patients who consume cannabis possessed “better hospitalization outcomes, including decreased length of stay and improved in-hospital mortality” as compared to those with no history of use.